Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
Showing page 276 |
first page | previous page | next page | last page |
Overall_Gscore | No. of Cancer Types | ||||
HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
PLCG1 | ENSG00000124181 | 0.00 | 0.00 | 0 | 0 |
MORC3 | ENSG00000159256 | 0.12 | 0.00 | 1 | 0 |
CROT | ENSG00000005469 | 0.00 | 0.00 | 0 | 0 |
HDAC5 | ENSG00000108840 | 0.00 | 0.36 | 0 | 2 |
ASXL1 | ENSG00000171456 | 0.23 | 0.00 | 1 | 0 |
PTAR1 | ENSG00000188647 | 0.00 | 0.11 | 0 | 1 |
NR2C2 | ENSG00000177463 | 0.16 | 0.18 | 1 | 1 |
PHF23 | ENSG00000040633 | 0.00 | 0.15 | 0 | 1 |
SLC25A13 | ENSG00000004864 | 0.11 | 0.00 | 1 | 0 |
IL10RB | ENSG00000243646 | 0.00 | 0.00 | 0 | 0 |
PVRL3 | ENSG00000177707 | 0.00 | 0.00 | 0 | 0 |
CYP19A1 | ENSG00000137869 | 0.00 | 0.00 | 0 | 0 |
ADRA1D | ENSG00000171873 | 0.00 | 0.00 | 0 | 0 |
CNP | ENSG00000173786 | 0.00 | 0.31 | 0 | 2 |
KLHL7 | ENSG00000122550 | 0.13 | 0.00 | 1 | 0 |
PA2G4 | ENSG00000170515 | 0.00 | 0.00 | 0 | 0 |
CDK14 | ENSG00000058091 | 0.00 | 0.00 | 0 | 0 |
NPEPL1 | ENSG00000215440 | 0.25 | 0.00 | 1 | 0 |
BTN3A2 | ENSG00000186470 | 0.00 | 0.00 | 0 | 0 |
AHCYL1 | ENSG00000168710 | 0.00 | 0.47 | 0 | 2 |
Showing page 276 |
first page | previous page | next page | last page |